Author

Huey-Ling Chen

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

A multicenter real-world study on the safety and effectiveness of the glucagon-like peptide-1 receptor agonist (liraglutide) in adolescents with obesity in Taiwan.

BACKGROUND AND AIMS Pediatric obesity is linked to many metabolic complications and has limited treatment options. We evaluated the safety and effectiveness of GLP-1 receptor agonist (liraglutide) in adolescents with obesity in clinical practice in Taiwan. METHODS We conducted a prospective study (NCT06283641) across...

Chiao-Fan Chiu, Chu-Kuang Chou, Shu-Wei Hu et al. · Obesity Research and Clinica... · 0 citations

Open access Jan 2026

Loci Associated With Susceptibility to Biliary Atresia-A Genome-Wide Association Study in Taiwan.

BACKGROUND Biliary atresia (BA) is the leading cause of pediatric liver transplantation worldwide. However, the genetic background remains unclear in most patients. In this genome-wide association study (GWAS), we aimed to identify genetic loci that contribute to susceptibility to BA. METHODS We recruited 189 BA pati...

Chieh-Yu Chu, Chi-San Tai, Chien-Ting Hsu et al. · Pediatrics International · 0 citations

Aug 2026

Vancomycin enriches Parabacteroides goldsteinii in the gut and promotes reconstruction of the hepatobiliary system in cholestasis.

Impaired bile secretion disrupts the gut microbiome and perpetuates cholestatic liver injury. Vancomycin (VCM) has been shown to improve cholestasis in human patients, but its biological effects remain unclear. This study aimed to investigate the therapeutic effects of VCM on microbiome modulation and the restoration o...

Shu-Hao Hsu, Huey‐Huey Chua, Bang‐Yu Liou et al. · Journal of Pathology · 0 citations